Grant for Multiple Sclerosis Innovation (GMSI) 2016
The Grant for Multiple Sclerosis Innovation (GMSI) 2016, a grant sponsored by Merck, offers up to €1,000,000 to academic researchers working to improve the understanding of Multiple Sclerosis (MS) for the ultimate benefit of patients. The grant is open to research applications until Monday 8th February 2016. Additional information about the grant can be found at http://www.grantformultiplesclerosisinnovation.org.
Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programs, mobile health devices, or patient-reported outcomes.